Regional and age-specific patterns of pandemic H1N1 influenza virus seroprevalence inferred from vaccine clinical trials, August-October 2009.

Euro surveillance : bulletin européen sur les maladies transmissibles = European communicable disease bulletin

Volumn 15, Issue 30, 2010, Pages

  Tsai, T F ^a   Pedotti, P ^b   Hilbert, A ^b   Lindert, K ^b   Hohenboken, M ^b   Borkowski, A ^b   Groth, N ^b   da Silva, L J ^b   Kyaw, M H ^b  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD; CHILD; CLINICAL TRIAL (TOPIC); EPIDEMIOLOGY; HEALTH; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A H1N1; MIDDLE AGED; PANDEMIC; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; PANDEMICS; SEROEPIDEMIOLOGIC STUDIES; WORLD HEALTH; YOUNG ADULT;

EID: 78751597122     PISSN: None     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (0)